NuMat (Specialty Chemicals) key facts
as of Oct 2026- Operator of engineered materials designed to capture and separate hazardous chemicals with precision.
- NuMat (Specialty Chemicals) is valued at approximately $251.0M as of Oct 2026 (last reported valuation).
- It has raised $78.0M; the latest was Later Stage VC ($59.0M) in May 2025.
- Notable investors include US National Science Foundation, U.S. Department of Energy, Aramco Ventures, EDBI, Arpa-E — 20 tracked in total.
- Status: Privately Held (backing).
NuMat (Specialty Chemicals)'s last reported valuation, May 2025. Nothing priced has surfaced since.
- ·The complete investor list: 20 names
- ·Watch NuMat (Specialty Chemicals): the Monday email on marks, rounds and moves
NuMat (Specialty Chemicals) funding rounds
No funding rounds for NuMat (Specialty Chemicals) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs NuMat (Specialty Chemicals)
20+NuMat (Specialty Chemicals) valuation
NuMat (Specialty Chemicals)'s last reported valuation was $251 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
NuMat (Specialty Chemicals) investors
20 investors are on record for NuMat (Specialty Chemicals), including US National Science Foundation, U.S. Department of Energy, Aramco Ventures and EDBI.
About NuMat (Specialty Chemicals)
Operator of engineered materials designed to capture and separate hazardous chemicals with precision. The company provides metal-organic frameworks used in defense, semiconductor, and industrial applications, enabling organizations to support national security requirements and global demand through a scalable, United States-based supply chain.
- Sector
- Materials and Resources
- HQ
- Chicago, IL, United States
- Founded
- 2012
- Employees
- 65
- Website
- numat.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.